title: Cheminformatics at the interface of medicinal chemistry and proteomics.
abstract: Multiple factors have to be optimized in the course of a drug discovery project. Traditionally this includes potency on a single target, eventually specificity as well as the pharmacokinetic, physicochemical and the safety profile. Recently an additional dimension has been added by realizing that the therapeutic outcome of a drug is often determined not only by its activity on a single target but also by its activity profile across a variety of biological targets. To address the polypharmacology of drug candidates many compounds are tested on a set of targets or in phenotypic screens generating a tremendous amount of data. To extract useful information computational methods at the interface of proteomics and cheminformatics are indispensable. This review will focus on some recent developments in this field. This article is part of a Special Issue entitled: Computational Proteomics in the Post-Identification Era. Guest Editors: Martin Eisenacher and Christian Stephan.
authors.affiliation: Lead Discovery Center GmbH, Otto-Hahn-Str. 15, D-44227 Dortmund, Germany. Electronic address: koch@lead-discovery.de.
authors.forename: Uwe
authors.initials: U
authors.lastname: Koch
authors.forename: Michael
authors.initials: M
authors.lastname: Hamacher
authors.forename: Peter
authors.initials: P
authors.lastname: Nussbaumer
mesh_terms: D002626:Chemistry, Pharmaceutical; D055808:Drug Discovery; D040901:Proteomics
keywords: Cheminformatics; Chemogenomics; Polypharmacology; Proteomics